FATE THERAPEUTICS INC Quarterly Common Stock, Shares, Issued from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Fate Therapeutics Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q3 2024.
  • Fate Therapeutics Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 114M shares, a 15.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 114M +15.3M +15.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 114M +15.3M +15.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 114M +15.6M +15.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 98.6M +1.33M +1.37% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 98.6M +1.47M +1.52% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 98.5M +1.66M +1.71% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 98.2M +1.65M +1.71% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 97.3M +1.57M +1.64% Dec 31, 2022 10-K 2024-02-26
Q3 2022 97.1M +1.75M +1.84% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 96.9M +2.6M +2.76% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 96.5M +2.65M +2.82% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 95.7M +8M +9.13% Dec 31, 2021 10-K 2023-02-28
Q3 2021 95.4M +8.36M +9.61% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 94.3M +7.46M +8.6% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 93.9M +17.9M +23.5% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 87.7M +12M +15.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 87M +11.6M +15.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 86.8M +21.5M +32.9% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 76M +10.9M +16.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 75.7M +11M +17.1% Dec 31, 2019 10-K 2021-02-24
Q3 2019 75.4M +10.9M +16.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 65.3M +11.9M +22.3% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 65.1M +12.3M +23.2% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 64.7M +12M +22.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 64.5M +23M +55.6% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 53.4M +12M +28.9% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 52.9M +11.5M +27.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 52.6M +11.3M +27.2% Dec 31, 2017 10-K 2019-03-05
Q3 2017 41.5M +7.31M +21.4% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 41.4M +12.5M +43.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 41.4M +12.5M +43.4% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 41.4M +12.7M +44.1% Dec 31, 2016 10-K 2018-03-05
Q3 2016 34.1M +5.43M +18.9% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 28.9M +265K +0.92% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 28.9M +8.22M +39.9% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 28.7M +8.15M +39.6% Dec 31, 2015 10-K 2017-03-16
Q3 2015 28.7M +8.15M +39.6% Sep 30, 2015 10-Q 2015-11-03
Q2 2015 28.6M +8.06M +39.2% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 20.6M +173K +0.85% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 20.6M +135K +0.66% Dec 31, 2014 10-K 2016-03-03
Q3 2014 20.6M +19.2M +1393% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 20.6M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 20.5M Mar 31, 2014 10-Q 2014-05-13
Q4 2013 20.4M +19.1M +1432% Dec 31, 2013 10-K 2015-03-12
Q3 2013 1.38M Sep 30, 2013 10-Q 2013-11-13
Q4 2012 1.33M Dec 31, 2012 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.